(Rac)-Upacicalcet
Modify Date: 2024-01-11 17:46:04
(Rac)-Upacicalcet structure
|
Common Name | (Rac)-Upacicalcet | ||
|---|---|---|---|---|
| CAS Number | 2649575-19-7 | Molecular Weight | 351.76 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C11H14ClN3O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (Rac)-Upacicalcet(Rac)-Upacicalcet is the racemate of Upacicalcet.Upacicalcet is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1]. |
| Name | (Rac)-Upacicalcet |
|---|
| Description | (Rac)-Upacicalcet is the racemate of Upacicalcet.Upacicalcet is an intravenous calcimimetic agent. Upacicalcet suppresses excessive parathyroid hormone (PTH) secretion, thereby lowering blood PTH levels, by acting directly on parathyroid cell membrane calcium-sensing receptors. Upacicalcet can be used for researching the disease of secondary hyperparathyroidism (SHPT)[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Hoy SM. Upacicalcet: First Approval. Drugs. 2021;81(13):1593-1596. |
| Molecular Formula | C11H14ClN3O6S |
|---|---|
| Molecular Weight | 351.76 |